A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

Clinical trial NCT01292239 · COMPLETED

Trial details

NCT number: NCT01292239
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2011-02-01
Primary completion: 2012-10-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.